Background: Diagnosing bone metastasis in patients without a history of cancer remains challenging.
Introduction
Treatment of bone metastasis has dramatically changed with the development of molecular-targeting drugs and bone-modifying agents 1 . Nevertheless, we still experience difficulties in diagnosing bone metastasis in patients without a history of cancer. These patients account for 25 to 30% of all cases of bone metastasis 2 . The diagnostic evaluation may be prolonged owing to the difficulty in distinguishing between bone metastasis and common orthopedic diseases 3, 4 .
Few studies have examined the difficulty of diagnosing bone metastasis in patients without a history of cancer, as well as the time to diagnosis and the adverse effects of a delay in diagnosis. Therefore, we retrospectively reviewed the clinical course of bone metastasis by comparing patients with and without a history of cancer. The hypothesis of this research was that making a diagnosis of bone metastasis in patients without a history of cancer would be more difficult than in patients with a history of cancer.
Materials and Methods
This retrospective study was approved by our institutional review board and was conducted in accordance with the Declaration of Helsinki. A retrospective review of consecutive patients with bone metastasis, including hematopoietic malignancies, was undertaken using medical records and images kept at our hospital for data on the diagnosis of first bone metastasis. This study was conducted at the orthopedic department of a single university hospital.
Patients
We retrospectively reviewed our institutional database by searching for all outpatients and inpatients with bone metastasis who visited our department for symptoms due to first bone metastasis between January 2011 and December 2014. Patients were classified as those with or without a history of cancer. Patients excluded from this study were: those diagnosed by staging or routine complete check-up after diagnosis of primary cancer without a previous visit to any clinic for bone metastasis; those diagnosed via routine health check-up without a previous visit to any clinic for bone metastasis; those who developed bone metastasis from sarcoma previously managed by our department; and those with insufficient information for review.
Methods
We evaluated the diagnostic rate at first visit, the period from onset of symptoms to first visit, the period from first visit to diagnosis of bone metastasis, and the presence of severe skeletal-related events, including pathological fracture, paralysis, and/or hypercalcemia at diagnosis of bone metastasis, and compared these between the two groups. The first visit was defined as the first visit to any clinic with symptoms of bone metastasis in this study. The initial diagnosis at first visit was classified as "bone metastasis or bone metastasis highly suspected," and others. "Bone metastasis highly suspected" was diagnosed when a practitioner planned further examination based on suspicion of bone metastasis. The diagnostic rate at the first visit was defined as the number of patients with "bone metastasis or bone metastasis highly suspected" divided by the total number of patients in each group. The day of diagnosis of bone metastasis was defined as the day of either having made a diagnosis or the day of treatment initiation. Evaluation of severe skeletal-related events of bone metastasis only included pathological fracture, paralysis, and hypercalcemia to eliminate ambiguity, because the materials available were limited to medical records and images at our hospital. In addition, impending fracture was not included in the definition of pathological fracture in this study to eliminate ambiguity. Paralysis was defined as motor disturbance or bladder or bowel disturbance caused by a disorder of the spinal cord, cauda equina, or nerve root, and not simple sensory disturbance, because the latter was thought to be difficult to distinguish from referred pain or numbness from the affected site in some cases in this retrospective review. Bone metastasis frequently occurs in multiple locations; thus, the location of bone metastasis in this study was defined as that most related to the main symptoms at first visit. The department at first visit was classified as orthopedics or others.
Patients were classified into Group A, those without a history of cancer, and Group B, those with a history of cancer.
Statistical Analysis
Continuous data were analyzed using the Mann-Whitney test, and data grouped into distinct categories were analyzed with the chi-square test. A two-sided pvalue of <0.05 was considered significant.
Results
A total of 129 patients visited our department for bone metastasis during the study period and were eligible for inclusion in this study. The flowchart outlines the process of grouping ( Fig. 1) . In 32 patients, first bone metastasis was diagnosed by staging or routine whole-body checkup after the diagnosis of a primary cancer. In one patient, first bone metastasis was diagnosed by a routine health check-up. One patient with a sarcoma who visited our hospital before first bone metastasis developed was excluded. Fourteen patients had insufficient information for review. The missing data for the period from onset to first visit was significant due to insufficient description of symptoms in the medical records. The remaining 81 patients were classified into Group A, those without a history of cancer (n=27), and Group B, those with a history of cancer (n=54). Demographic characteristics of the patients in the two groups are shown in Table 1 . Table 2 summarizes the results for diagnostic rate at first visit, period from onset to first visit, period from first visit to diagnosis of bone metastasis, and frequency of associated severe skeletal-related events at diagnosis. At the first visit, "bone metastasis" or "bone metastasis highly suspected" was diagnosed in only 3 of 27 Group A patients. These 3 patients had pathological fractures in long bones at first visit. The diagnostic rate was significantly lower in Group A than in Group B. Diagnoses other than bone metastasis at first visit are summarized in Figure 2 . While there was no significant difference in the period from onset of symptoms to first visit between the two groups, the period from first visit to diagnosis was significantly longer in Group A than in Group B.
Pathological fracture, paralysis, and/or hypercalcemia were seen in 81.4% of patients in Group A at diagnosis of bone metastasis. This was significantly higher than in Group B. Table 3 summarizes severe skeletal-related events of bone metastasis at diagnosis of bone metastasis in both groups. 
(Group A)
Patients with a history of cancer (n = 54)
(Group B)
Data available for analysis Diagnosis at first visit (n = 26) Period (onset to first visit) (n = 18) Period (first visit to diagnosis) (n = 26) Skeletal-related events (n = 27) Data available for analysis Diagnosis at first visit (n = 42) Period (onset to first visit) (n = 50) Period (first visit to diagnosis) (n = 54) Skeletal-related events (n = 54) 
Discussion
The most important finding of this study was that the diagnosis of bone metastasis in patients without a history of cancer is significantly more difficult to make compared with that in patients with a history of cancer, based on evaluation of the diagnostic rate, the time to diagnosis, and the rate of severe skeletal-related events. The first conclusion of this study was that making a diagnosis of The results of the present study indicate that it is very difficult to diagnose bone metastasis in patients without a history of cancer. Accordingly, this must be considered in the early diagnosis of bone metastasis to prevent skeletal-related events. It is important to pay attention to the possibility that bone metastases may be present in follow-up observation even if there have been no findings that led to the diagnosis of bone metastasis at first visit. According to the progress of symptoms, it may be necessary to perform additional examinations such as reexamination of plain radiography or other imaging at an early stage before occurrence of any severe skeletalrelated events. We believe that our results can contribute to the improvement of the early diagnosis of bone metastasis due to occult malignancy.
